HRCT in Prediction of Tumor Invasion in GGO Lung Adenocarcinoma (ECTOP-1008)
NCT04165759 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 620
Last updated 2023-07-21
Summary
This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1008). It aims to evaluate the correlation between radiological diagnosis based on HRCT and pathological invasiveness.Investigators observe the radiological features and the correlation with the postoperative pathological findings.
Conditions
- Adenocarcinoma of Lung
Sponsors & Collaborators
-
Fujian Medical University Union Hospital
collaborator OTHER -
Shandong First Medical University Affiliated Liaocheng Second Hospital
collaborator UNKNOWN -
Jiangdu People's Hospital, Yangzhou
collaborator UNKNOWN -
Fudan University
lead OTHER
Principal Investigators
-
Haiquan Chen · Fudan University
Eligibility
- Min Age
- 15 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-18
- Primary Completion
- 2021-04-30
- Completion
- 2021-07-01
Countries
- China
Study Locations
More Related Trials
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
NCT05925751 ·Status: UNKNOWN
-
Study of CT and MR in the Lung Cancer
NCT04034667 ·Status: UNKNOWN
-
Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015)
NCT05794711 ·Status: UNKNOWN
-
Feasibility Study of Radiation Therapy With Wide Detector 4DCT Scanning for Primary or Metastatic Lung Cancer
NCT06233396 ·Status: COMPLETED
-
Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005)
NCT03591445 ·Status: COMPLETED ·Phase: NA
-
Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma
NCT05830812 ·Status: RECRUITING
-
Retrospective Analysis of Clinical and CT Features to Predict Spread Through Air Space in Stage IA Lung Adenocarcinoma
NCT06645743 ·Status: NOT_YET_RECRUITING
-
Radiomics Combined With Frozen Section Prediction Model for Spread Through Air Space in Lung Adenocarcinoma
NCT05400304 ·Status: UNKNOWN
-
Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy
NCT04741633 ·Status: UNKNOWN
-
Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer
NCT05925738 ·Status: UNKNOWN
-
CT-based Radiomic Algorithm for Assisting Surgery Decision and Predicting Immunotherapy Response of NSCLC
NCT04452058 ·Status: UNKNOWN
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217 ·Status: RECRUITING
-
Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer
NCT02320617 ·Status: UNKNOWN ·Phase: NA
-
Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC
NCT04984148 ·Status: UNKNOWN
-
99mTc-H7ND SPECT/CT Imaging in NSCLC
NCT05999214 ·Status: RECRUITING ·Phase: NA
-
Improving Pulmonary Function Following Radiation Therapy
NCT02843568 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function
NCT03357094 ·Status: UNKNOWN
-
Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
NCT02898441 ·Status: UNKNOWN ·Phase: NA
-
Benefit of Spectral Information in Patients Suspected for Lung Cancer
NCT06440616 ·Status: RECRUITING ·Phase: NA
-
Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016)
NCT05794724 ·Status: UNKNOWN
-
Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy
NCT07312682 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors
NCT05834413 ·Status: RECRUITING ·Phase: NA
-
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
NCT04276025 ·Status: COMPLETED